Cargando…

JAK Inhibitors and Modulation of B Cell Immune Responses in Rheumatoid Arthritis

Rheumatoid arthritis (RA) is a chronic, systemic immune-mediated inflammatory disease that can lead to joint destruction, functional disability and substantial comorbidity due to the involvement of multiple organs and systems. B cells have several important roles in RA pathogenesis, namely through a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moura, Rita A., Fonseca, João Eurico
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7892604/ https://www.ncbi.nlm.nih.gov/pubmed/33614673 http://dx.doi.org/10.3389/fmed.2020.607725

Ejemplares similares

B Cells on the Stage of Inflammation in Juvenile Idiopathic Arthritis: Leading or Supporting Actors in Disease Pathogenesis?
por: Moura, Rita A., et al.
Publicado: (2022)

Editorial: Risk factors for Rheumatoid Arthritis and pre-Rheumatoid Arthritis
por: Sapart, Emillie, et al.
Publicado: (2022)

Disease mechanisms in preclinical rheumatoid arthritis: A narrative review
por: Romão, Vasco C., et al.
Publicado: (2022)

Etiology and Risk Factors for Rheumatoid Arthritis: A State-of-the-Art Review
por: Romão, Vasco C., et al.
Publicado: (2021)

Diet, Microbiota, and Gut Permeability—The Unknown Triad in Rheumatoid Arthritis
por: Guerreiro, Catarina Sousa, et al.
Publicado: (2018)

Diet as a Modulator of Intestinal Microbiota in Rheumatoid Arthritis
por: Dourado, Eduardo, et al.
Publicado: (2020)

Histopathology of Psoriatic Arthritis Synovium—A Narrative Review
por: Tenazinha, Catarina, et al.
Publicado: (2022)

Response measures influence comparative effectiveness of biological drugs in rheumatoid arthritis
por: Canhao, Helena, et al.
Publicado: (2012)

JAK inhibitors differentially modulate B cell activation, maturation and function: A comparative analysis of five JAK inhibitors in an in-vitro B cell differentiation model and in patients with rheumatoid arthritis
por: Frede, Natalie, et al.
Publicado: (2023)

Editorial: Synovial Tissue: Turning the Page to Precision Medicine in Arthritis?
por: Orr, Carl Kieran, et al.
Publicado: (2021)

Clinical use of Jak 1 inhibitors for rheumatoid arthritis
por: Nash, Peter
Publicado: (2021)

Clinical efficacy of launched JAK inhibitors in rheumatoid arthritis
por: Taylor, Peter C
Publicado: (2019)

Hi-JAKi-ng Synovial Fibroblasts in Inflammatory Arthritis With JAK Inhibitors
por: Burja, Blaž, et al.
Publicado: (2020)

Celastrol Efficacy by Oral Administration in the Adjuvant-Induced Arthritis Model
por: Cascão, Rita, et al.
Publicado: (2020)

The JAK inhibitor tofacitinib suppresses synovial JAK1-STAT signalling in rheumatoid arthritis
por: Boyle, D L, et al.
Publicado: (2015)

JAK-inhibitors. New players in the field of immune-mediated diseases, beyond rheumatoid arthritis
por: Fragoulis, George E, et al.
Publicado: (2019)

Growing evidence of the safety of JAK inhibitors in patients with rheumatoid arthritis
por: Harigai, Masayoshi
Publicado: (2019)

A JAK Inhibitor for Treatment of Rheumatoid Arthritis: The Baricitinib Experience
por: Taylor, Peter C., et al.
Publicado: (2023)

Common Evaluations of Disease Activity in Rheumatoid Arthritis Reach Discordant Classifications across Different Populations
por: Canhão, Helena, et al.
Publicado: (2018)

Effective natural inhibitors targeting granzyme B in rheumatoid arthritis by computational study
por: Wang, Xinyu, et al.
Publicado: (2022)

B-cell phenotype and IgD-CD27- memory B cells are affected by TNF-inhibitors and tocilizumab treatment in rheumatoid arthritis
por: Moura, Rita A., et al.
Publicado: (2017)

Real-world comparative effectiveness of bDMARDs and JAK inhibitors in elderly patients with rheumatoid arthritis
por: Temmoku, Jumpei, et al.
Publicado: (2022)

Old drugs, old problems: where do we stand in prediction of rheumatoid arthritis responsiveness to methotrexate and other synthetic DMARDs?
por: Romão, Vasco Crispim, et al.
Publicado: (2013)

Phase III trials of JAK1 selective inhibitors in rheumatoid arthritis
por: Mysler, Eduardo, et al.
Publicado: (2021)

Early phase studies of JAK1 selective inhibitors in rheumatoid arthritis
por: Avci, Ali Berkant, et al.
Publicado: (2021)

Clinical utility of the oral JAK inhibitor tofacitinib in the treatment of rheumatoid arthritis
por: Cutolo, Maurizio, et al.
Publicado: (2013)

Efficacy and Safety of JAK Inhibitors for Rheumatoid Arthritis: A Meta-Analysis
por: Wang, Faping, et al.
Publicado: (2022)

Interleukin-34-regulated T-cell responses in rheumatoid arthritis
por: Park, Hye Eun, et al.
Publicado: (2022)

Early response to JAK inhibitors on central sensitization and pain catastrophizing in patients with active rheumatoid arthritis
por: Salaffi, Fausto, et al.
Publicado: (2022)

Circulating Biomarkers and Cardiac Structure and Function in Rheumatoid Arthritis
por: Kobayashi, Masatake, et al.
Publicado: (2021)

Rheumatoid arthritis and mitochondrial homeostasis: The crossroads of metabolism and immunity
por: Cui, Liu, et al.
Publicado: (2022)

Discovery of a highly selective JAK3 inhibitor for the treatment of rheumatoid arthritis
por: Pei, Heying, et al.
Publicado: (2018)

JAK-Inhibitors for the Treatment of Rheumatoid Arthritis: A Focus on the Present and an Outlook on the Future
por: Angelini, Jacopo, et al.
Publicado: (2020)

JAK Inhibitors in Rheumatoid Arthritis: An Evidence-Based Review on the Emerging Clinical Data
por: Harrington, Robert, et al.
Publicado: (2020)

Remission Induced by TNF Inhibitors Plus Methotrexate is Associated With Changes in Peripheral Naïve B Cells in Patients With Rheumatoid Arthritis
por: Hernández-Breijo, Borja, et al.
Publicado: (2021)

Gastric Adenocarcinoma Presenting as a Rheumatoid Factor and Anti-cyclic Citrullinated Protein Antibody-Positive Polyarthritis: A Case Report and Review of Literature
por: Silvério-António, Manuel, et al.
Publicado: (2021)

Probiotic Supplementation for Rheumatoid Arthritis: A Promising Adjuvant Therapy in the Gut Microbiome Era
por: Ferro, Margarida, et al.
Publicado: (2021)

Pulmonary nodules associated with JAK inhibitor therapy in rheumatoid arthritis: A case report
por: Pannell, N, et al.
Publicado: (2021)

Preclinical Characterization of the Selective JAK1 Inhibitor LW402 for Treatment of Rheumatoid Arthritis
por: Zhang, Ning, et al.
Publicado: (2021)

Efficacy of Monotherapy with Biologics and JAK Inhibitors for the Treatment of Rheumatoid Arthritis: A Systematic Review
por: Emery, Paul, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ln987b37i7fq10gebce4gg3e7r